SAMRAT PHARMACHEM
Back to Balance Sheet
|
SAMRAT PHARMACHEM Last 5 Year Net Current Assets History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Current Assets (Including Current Investments) | ₹46 Cr | ₹46 Cr | ₹34 Cr | ₹20 Cr | ₹16 Cr |
What is the latest Net Current Assets ratio of SAMRAT PHARMACHEM ?
Year | Net Current Assets |
---|---|
Mar2024 | ₹46 Cr |
Mar2023 | ₹46 Cr |
Mar2022 | ₹34 Cr |
Mar2021 | ₹20 Cr |
Mar2020 | ₹16 Cr |
How is Net Current Assets of SAMRAT PHARMACHEM Trending?
Years | Net Current Assets | % Change | |
---|---|---|---|
Mar2024 | ₹46 Cr | 0.66 | |
Mar2023 | ₹46 Cr | 35.16 | |
Mar2022 | ₹34 Cr | 69.69 | |
Mar2021 | ₹20 Cr | 26.72 | |
Mar2020 | ₹16 Cr | - |
Compare Net Current Assets of peers of SAMRAT PHARMACHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SAMRAT PHARMACHEM | ₹106.0 Cr | -5.6% | -2.6% | -8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,648.0 Cr | -3.4% | -0.2% | 18.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,310.0 Cr | -2.3% | 3.4% | 55.5% | Stock Analytics | |
CIPLA | ₹119,410.0 Cr | -2.6% | -0.6% | 5.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,189.0 Cr | -2.3% | -2.1% | 20.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,496.4 Cr | -2.9% | -0.2% | -8.7% | Stock Analytics |
SAMRAT PHARMACHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SAMRAT PHARMACHEM | -5.6% |
-2.6% |
-8% |
SENSEX | -1.3% |
4.1% |
7.6% |
You may also like the below Video Courses